Analysts expect Humacyte, Inc. to report revenue of 723,023.57 for Q3 26, against a range of 659,254.34 to 786,792.80. The most recent reported quarter, Q2 26, came in at 406,000.00, a 63.4% miss against the 1.11 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 517,000.00 | 301,000.00 | 753,000.00 | 467,000.00 | 495,000.00 | 406,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 770,333.06 | 1.11 M | 934,025.97 | 1.39 M | 1.64 M | 1.19 M | 786,792.80 | 2.08 M | 1.95 M | 3.20 M | 3.99 M | 4.70 M | 26.48 M | 28.41 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 693,329.76 | 980,196.92 | 845,974.67 | 1.24 M | 1.42 M | 1.03 M | 659,254.34 | 1.73 M | 1.75 M | 2.67 M | 3.49 M | 4.29 M | 22.42 M | 24.05 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 731,831.41 | 1.04 M | 890,000.32 | 1.32 M | 1.53 M | 1.11 M | 723,023.57 | 1.91 M | 1.85 M | 2.93 M | 3.74 M | 4.49 M | 24.45 M | 26.23 M |
Analysts expect Humacyte, Inc. to report earnings per share of -0.10 for Q3 26, against a range of -0.11 to -0.09. The most recent reported quarter, Q2 26, came in at -0.16, a 45.5% miss against the -0.11 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.33 | -0.16 | 0.28 | -0.24 | -0.11 | -0.13 | -0.09 | -0.16 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.22 | -0.23 | -0.18 | -0.15 | -0.13 | -0.12 | -0.11 | -0.11 | -0.09 | -0.08 | -0.07 | -0.07 | -0.02 | -0.02 | -0.03 | -0.12 | ||||||||||
| Low Estimate | -0.26 | -0.25 | -0.22 | -0.19 | -0.15 | -0.14 | -0.13 | -0.11 | -0.11 | -0.10 | -0.09 | -0.09 | -0.02 | -0.02 | -0.03 | -0.14 | ||||||||||
| Consensus Estimate | -0.24 | -0.24 | -0.20 | -0.17 | -0.14 | -0.13 | -0.12 | -0.11 | -0.10 | -0.09 | -0.08 | -0.08 | -0.02 | -0.02 | -0.03 | -0.13 |
Pull Wall Street consensus for Humacyte, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=HUMA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "HUMA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=HUMA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();